"
Team:Tufts/future
From 2014.igem.org
(Difference between revisions)
| Line 10: | Line 10: | ||
<div class="col-md-6"> | <div class="col-md-6"> | ||
This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy. | This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy. | ||
| - | <br> | + | <br><br> |
The conference incorporated two main events. The first a discussion between experts, held | The conference incorporated two main events. The first a discussion between experts, held | ||
under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage | under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage | ||
Revision as of 22:55, 17 October 2014
This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy.
The conference incorporated two main events. The first a discussion between experts, held under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage application and associated safety and regulatory considerations. This was followed by a public forum to present and discuss the results and implications with a more general audience before shifting to guided and informal discussion.
Application Scenarios
Techno-Moral Scenarios
Survey
The conference incorporated two main events. The first a discussion between experts, held under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage application and associated safety and regulatory considerations. This was followed by a public forum to present and discuss the results and implications with a more general audience before shifting to guided and informal discussion.
